MeSH Browser

MeSH Supplementary: ogalvibart, crexavibart drug combination
Unique ID: C000712627
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C000712627
Entry Term(s): BMS-986413 and BMS-986414; BMS-986413 and BMS-986414 drug combination; BMS-986413, BMS-986414 drug combination; C-144-LS and C-135-LS; C-144-LS and C-135-LS drug combination; C-144-LS, C-135-LS; C-144-LS, C-135-LS drug combination; C144-LS and C-135-LS drug combination; C144-LS and C135-LS drug combination; C144-LS, C-135-LS drug combination; C144-LS, C135-LS drug combination; IM-051; IM051; ogalvibart and crexavibart; ogalvibart and crexavibart drug combination
Registry Numbers: 0
Heading Mapped to: Drug Combinations; *Antibodies, Neutralizing; *Antibodies, Monoclonal, Humanized
Frequency: 0
Note: combination of two neutralizing anti-SARS-CoV-2 mAbs targeting epitopes on the receptor protein binding domain (RBD) of the SARS-CoV-2 spike protein
Date of Entry: 2021/01/25
Revision Date: 2022/05/27

ogalvibart, crexavibart drug combination MeSH Supplementary Concept Data 2025